Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer.

Authors:
Lang Y; Lin Y; Deng M; Liu X.

Journal:
BMC Cancer

Publication Year: 2024

DOI:
10.1186/s12885-024-11992-6

PMCID:
PMC10880349

PMID:
38383374

View on PubMed View on PMC View Publisher
Journal Information

Full Title: BMC Cancer

Abbreviation: BMC Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of proliferation and me…
Chen HC; Kuo CY; Chang Y and 5 more (2024) - Transparency Score: 3/6
Accelerated enhanced recovery after colon cancer surgery with discharge within one day after surger…
Sier MAT; Gielen AHC; Tweed TTT and 3 more (2024) - Transparency Score: 4/6
Access to oncology care in Mali: a qualitative study on breast cancer.
Schantz C; Coulibaly A; Traoré A and 6 more (2024) - Transparency Score: 3/6
A cost-benefit analysis of genetic screening test for breast cancer in Iran.
Meshkani Z; Moradi N; Aboutorabi A and 2 more (2024) - Transparency Score: 3/6
A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a poly…
Zhao Z; Gu S; Yang Y and 4 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis analysis utilized modeling techniques, and no human participants were involved. Institutional review board approval or informed consent was not necessary, as the study relied on publicly available data from literature and an open database, rather than individual patient data. Consent for publicationNot Applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by Professional Talent Team Construction project of Huangpu District Health System of Shanghai (grant number: 2023XD03) and authors' organization."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025